Pharmacological modulation of ion channels and transporters

Ursula Ravens, Erich Wettwer, O. Hála

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Ion channels and transporter proteins are prerequisites for formation and conduction of cardiac electrical impulses. Acting in concert, these proteins maintain cellular Na+ and Ca2+ homeostasis. Since intracellular Ca2+ concentration determines contractile activation, we expect the majority of agents that modulate activity of ion channels and transporters not only to influence cellular action potentials but also contractile force. Drugs which block ion channels usually possess antiarrhythmic properties, those inhibiting the Na+ pump have predominantly inotropic effects and those affecting Na+,Ca2+- or Na+,H+-exchanger protect against ischaemic cell damage. However, irrespective of their primary indication, all compounds targeted against ion channels and transporter proteins possess potential proarrhythmic activity.

Original languageEnglish
Pages (from-to)575-582
Number of pages8
JournalCell Calcium
Volume35
Issue number6
DOIs
Publication statusPublished - Jun 2004

Fingerprint

Ion Channels
Pharmacology
Sodium-Hydrogen Antiporter
Proteins
Action Potentials
Homeostasis
Pharmaceutical Preparations

Keywords

  • Antiarrhythmic drugs
  • Cardiac myocytes
  • Inotropic drugs
  • Ion channels
  • Ion transporters

ASJC Scopus subject areas

  • Cell Biology
  • Endocrinology

Cite this

Pharmacological modulation of ion channels and transporters. / Ravens, Ursula; Wettwer, Erich; Hála, O.

In: Cell Calcium, Vol. 35, No. 6, 06.2004, p. 575-582.

Research output: Contribution to journalArticle

Ravens, Ursula ; Wettwer, Erich ; Hála, O. / Pharmacological modulation of ion channels and transporters. In: Cell Calcium. 2004 ; Vol. 35, No. 6. pp. 575-582.
@article{14d9832f65df4510ab607d56911d2554,
title = "Pharmacological modulation of ion channels and transporters",
abstract = "Ion channels and transporter proteins are prerequisites for formation and conduction of cardiac electrical impulses. Acting in concert, these proteins maintain cellular Na+ and Ca2+ homeostasis. Since intracellular Ca2+ concentration determines contractile activation, we expect the majority of agents that modulate activity of ion channels and transporters not only to influence cellular action potentials but also contractile force. Drugs which block ion channels usually possess antiarrhythmic properties, those inhibiting the Na+ pump have predominantly inotropic effects and those affecting Na+,Ca2+- or Na+,H+-exchanger protect against ischaemic cell damage. However, irrespective of their primary indication, all compounds targeted against ion channels and transporter proteins possess potential proarrhythmic activity.",
keywords = "Antiarrhythmic drugs, Cardiac myocytes, Inotropic drugs, Ion channels, Ion transporters",
author = "Ursula Ravens and Erich Wettwer and O. H{\'a}la",
year = "2004",
month = "6",
doi = "10.1016/j.ceca.2004.01.011",
language = "English",
volume = "35",
pages = "575--582",
journal = "Cell Calcium",
issn = "0143-4160",
publisher = "Churchill Livingstone",
number = "6",

}

TY - JOUR

T1 - Pharmacological modulation of ion channels and transporters

AU - Ravens, Ursula

AU - Wettwer, Erich

AU - Hála, O.

PY - 2004/6

Y1 - 2004/6

N2 - Ion channels and transporter proteins are prerequisites for formation and conduction of cardiac electrical impulses. Acting in concert, these proteins maintain cellular Na+ and Ca2+ homeostasis. Since intracellular Ca2+ concentration determines contractile activation, we expect the majority of agents that modulate activity of ion channels and transporters not only to influence cellular action potentials but also contractile force. Drugs which block ion channels usually possess antiarrhythmic properties, those inhibiting the Na+ pump have predominantly inotropic effects and those affecting Na+,Ca2+- or Na+,H+-exchanger protect against ischaemic cell damage. However, irrespective of their primary indication, all compounds targeted against ion channels and transporter proteins possess potential proarrhythmic activity.

AB - Ion channels and transporter proteins are prerequisites for formation and conduction of cardiac electrical impulses. Acting in concert, these proteins maintain cellular Na+ and Ca2+ homeostasis. Since intracellular Ca2+ concentration determines contractile activation, we expect the majority of agents that modulate activity of ion channels and transporters not only to influence cellular action potentials but also contractile force. Drugs which block ion channels usually possess antiarrhythmic properties, those inhibiting the Na+ pump have predominantly inotropic effects and those affecting Na+,Ca2+- or Na+,H+-exchanger protect against ischaemic cell damage. However, irrespective of their primary indication, all compounds targeted against ion channels and transporter proteins possess potential proarrhythmic activity.

KW - Antiarrhythmic drugs

KW - Cardiac myocytes

KW - Inotropic drugs

KW - Ion channels

KW - Ion transporters

UR - http://www.scopus.com/inward/record.url?scp=2442532944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442532944&partnerID=8YFLogxK

U2 - 10.1016/j.ceca.2004.01.011

DO - 10.1016/j.ceca.2004.01.011

M3 - Article

C2 - 15110147

AN - SCOPUS:2442532944

VL - 35

SP - 575

EP - 582

JO - Cell Calcium

JF - Cell Calcium

SN - 0143-4160

IS - 6

ER -